Texture analysis methods for injectable and transdermal drug delivery — microneedle penetration force, ISO 7886 syringe glide force, and ASTM D882 patch peel adhesion.
A microneedle penetration test is a quantitative compression measurement performed on a texture analyzer to confirm that a microneedle array can pierce skin at the insertion forces typical of combination drug-device products — roughly 0.1–10 N per 10×10 array and 0.001–5 N per individual needle. The same class of instrument covers the other two injectable and transdermal applications most combination-product teams need: syringe break-loose and glide force per ISO 7886-1 and ISO 11040-4 (typically 3–20 N), and transdermal patch peel strength per ASTM D882 and ASTM D3330 (typically 0.1–2 N/cm).
This hub explains how the KHT TA-30 Pharmaceutical Texture Analyzer handles all three with a single platform, 0.01 N force resolution, and 21 CFR Part 11–compliant data capture out of the box.
Injectable and transdermal products are the fastest-growing segment of combination drug-device development. Three distinct mechanical tests dominate QC and release workflows for this segment, and each one depends on the same core instrument capability — a low-force, high-resolution texture analyzer that can apply controlled compression, tension, and peel motion with sub-milligram force sensitivity.
The three workflows differ in sample geometry and regulatory anchor, but they share a common need: force and displacement data traceable to a validated instrument, with every run captured under an audit trail. A combination drug-device team that buys three separate rigs typically spends 2.5–3× more than a single multi-application platform, without gaining accuracy.
Microneedle (MN) arrays deliver drug into the viable epidermis without the pain, needle phobia, or sharps waste of conventional injections. For the array to work, every needle must penetrate the stratum corneum — the 10–20 µm keratinised outer skin layer — without buckling, shearing, or fracturing prematurely.
For a 10×10 array (100 needles), total array insertion force is typically 0.1–10 N. Dissolving microneedles made from hyaluronic acid, polyvinyl alcohol, or trehalose can fail at loads below 1 N per needle — meaning a texture analyzer with 0.1 N resolution cannot reliably detect the fracture event. The KHT TA-30's 0.01 N force resolution gives combination drug-device developers the signal-to-noise ratio needed to set meaningful batch release specifications.
Syringe force testing has the most mature regulatory framework of the three injectable/transdermal applications. The governing standard is ISO 7886-1:2017 for sterile hypodermic syringes for single use, with ISO 11040-4 covering glass prefilled syringes specifically. For auto-injectors and pen injectors, ISO 11608-1 provides the activation force framework.
Every syringe produces two distinct forces: break-loose force (F1) — the peak force to initiate plunger movement after static storage (typically 4–20 N) — and glide force (F2) — the steady-state force during 100 mm/s plunger travel (typically 3–15 N). Both failure modes directly affect patient dosing accuracy and auto-injector reliability.
Transdermal drug delivery is the fastest-growing texture-testing application in pharma (AAPS PharmSciTech, 2025). The adhesive that holds a transdermal patch on skin for 24, 72, or 168 hours must balance four mechanical properties: peel strength (ASTM D3330 Method A, typically 0.1–2 N/cm), tack (probe or loop tack, 0.5–10 N), shear resistance, and cold flow. All four measurements are performed on the same texture analyzer with different fixtures.
A single KHT TA-30 configured with a 50 N load cell (or 500 N dual-range) plus the three accessory kits — microneedle compression platen, syringe activation rig, and 180° peel fixture — covers every injectable and transdermal application listed on this page. Universal probe interface means third-party fixtures from SMS, Brookfield, or custom fabricators mount directly without adapters.
The KHT TA-30 includes 21 CFR Part 11–compliant audit trails, electronic signatures, and user access controls as standard, and ships with the IQ/OQ/PQ validation package needed for GMP lab qualification.
| Standard | Scope | Typical Force Range | KHT TA-30 Coverage |
|---|---|---|---|
| ISO 7886-1:2017 | Sterile hypodermic syringes — plunger force | 3–20 N | Meets — 0.01 N resolution, 100 mm/s test speed |
| ISO 11040-4 | Glass prefilled syringes — functional performance | 3–15 N | Meets — dedicated syringe rig, 50 N load cell |
| ISO 11608-1 | Needle-based injection systems (auto-injectors) | 5–50 N | Meets — 500 N load cell option, trigger-force detection |
| ISO 7864 | Sterile hypodermic needles | N/A (geometry) | Needle penetration rig available |
| ASTM D882 | Tensile properties of thin plastic sheeting | 0.1–50 N | Meets — tensile grips, 0.001 mm displacement |
| ASTM D3330 Method A | 180° peel adhesion | 0.1–2 N/cm | Meets — 180° peel fixture, low-force load cell |
| 21 CFR Part 11 | Electronic records & signatures | N/A | Standard, not optional — audit trail + e-sig built in |
| USP <1207> | Package integrity | Varies | Container closure integrity fixtures available |
| Parameter | Typical Range | Acceptance Criterion (example) | Test |
|---|---|---|---|
| Microneedle insertion force (per needle) | 0.05–0.5 N | ≥ 0.08 N per needle | Microneedle compression |
| Microneedle array insertion force (10×10) | 0.1–10 N | ≥ 3 N total | Microneedle compression |
| Microneedle fracture force | 0.2–5 N per needle | ≥ 2× insertion force | Compression to failure |
| Syringe break-loose force (F1) | 4–20 N | ≤ 15 N | ISO 7886-1 plunger test |
| Syringe glide force (F2) | 3–15 N | ≤ 10 N | ISO 7886-1 plunger test |
| Auto-injector activation force | 15–50 N | Per device spec | ISO 11608-1 trigger test |
| Patch 180° peel strength | 0.1–2 N/cm | 0.3–1.5 N/cm | ASTM D3330 Method A |
| Patch probe tack | 0.5–10 N | Per in-house spec | Probe tack method |
Common questions about microneedle, syringe, and transdermal patch texture analysis.
Transparent $8,000–$13,000 pricing. Every quote includes the IQ/OQ/PQ validation package, 30+ method library, 21 CFR Part 11 software, standard probe set, and 2-year warranty. Response within 24 hours; engineering SLA within 48 hours.
© 2026 KHT Pharmaceutical Texture Analyzer | pharmaceuticaltextureanalyzer.com